Seno Medical Instruments, Inc., the company pioneering opto-acoustic imaging as a tool to improve the diagnosis of cancer, announced today that the first 100 patients have been enrolled into its Pivotal Study of Imagio™, a new opto-acoustic imaging system that may help women with benign breast masses avoid negative, invasive biopsies.

The Medical Imaging & Technology Alliance (MITA) today announced its support of the pilot program for the Medical Device Single Audit Program (MDSAP), the details of which were unveiled this week at the November 2013 IMDRF Stakeholder Meetings.

Patients undergoing conventional mammography paired with tomosynthesis had significantly lower screening recall rates than those receiving mammography alone, according to a study published in the December issue of Radiology.

20/20 Imaging, a leader in small market imaging with nearly 2,500 installations across the country, announced today their product line-up for RSNA 2013, led by a new digital x-ray system with enhanced software capabilities and higher frequency generator.

Gamma Medica, Inc. debuts a range of enhancements to its LumaGEM molecular breast imaging (MBI) system at the Radiological Society of North America (RSNA) 2013 conference, as the company expands sales and marketing efforts for its groundbreaking breast imaging technology.

Healthcare providers searching for a CT system that offers the best in usability, dose management and scalability now have a solution with Toshiba’s all-new AquilionTM PRIME. The system delivers on customers’ clinical and financial needs today, with the ability to adapt as those needs change in the future.

In support of National Breast Cancer Awareness Month, OneMedNet Corporation is launching the BEAM™ Women’s Health Image Exchange service. This low-cost service enables breast imaging centers and radiology departments to quickly transfer a patient’s mammograms to another care provider for comparison, consultation, or treatment and eliminate delays associated with conventional delivery methods.

A single dose of targeted radiation during surgical treatment for early breast cancer could be an alternative to a standard multiweek course of radiotherapy, according to a pair of studies published in The Lancet and The Lancet Oncology.